Mr. Lapointe is the CEO of Optina Diagnostics. In 2001, Mr Lapointe founded Advanced Molecular Imaging (AMI) in Sherbrooke, Canada to bring molecular imaging technologies to the global pharma and research market. David successfully secured all funding for AMI and completed the sale of AMI to Gamma Media-Ideas (GMI). While at GMI, David facilitated a global distribution agreement with GE Healthcare for all GMI products. Mr. Lapointe went on to

Dr. Jean Daniel Arbour heads the ophthalmology department of the faculty of medicine at the University of Montreal, where he is also associate professor. After receiving his M.D. from the University of Montreal, Dr. Arbour interned in general surgery, specialized in ophthalmology and then went to Harvard University for medical and surgical retina training. At Harvard, Dr. Arbour also conducted research on macular degeneration and photodynamic

Dr. Jean-Philippe Sylvestre joined Photon etc. in 2011 as the Scientist responsible of the development of the hyperspectral retinal camera. In addition to leading the technical development of the instrument and clinical applications, he was in charge of the ethical and regulatory aspects of the project. Dr. Sylvestre obtained his PhD in Pharmaceutical Sciences after completing his degree and his MSc in Engineering Physics. He possesses more than

In 1994, Denis co-founded Innova Ophthalmic Instruments that developed into the Canadian market leader. While vice president of business development at Innova, Mr. Sarrazin completed several distribution agreements with ophthalmic manufacturers. He also supported a multidisciplinary project with the University of Montreal managing the development of a technology platform for research on the eye and vision.